Biochemical response to enzalutamide therapy in patients with mCRPC following docetaxel and abiraterone treatment. This is an ASCO Meeting Abstract from the 2014 Genitourinary Cancers Symposium. This ...

Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Whole-transcriptome sequencing (RNA-seq) is an essential technique for revealing gene expression patterns, pathways, and biomarkers related to disease states or potential therapeutics. Once key gene ...

Introduction Although the focus of the genomics community has largely been on DNA polymorphisms which affect disease risk, gene expression, especially of blood cells, has the potential to reflect ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced clinical results from the global, randomized, double-blind placebo-controlled Phase 2 FIGHT ...